Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bausch Health Companies Inc

Exact Sciences

More coronavirus worries. More misery for these healthcare stocks.

Why Align Technology, Bausch Health, and Exact Sciences Stocks Tanked Today

Shockwave Medical

Why Exact Sciences, Align Technology, and ShockWave Medical Shares Are Plunging Today

Investors are now even more worried about the impact of coronavirus disease COVID-19.

Why Align Technology Stock Sank Today

SAN JOSE, Calif., March  10, 2020  (GLOBE NEWSWIRE) -- Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced the creation of a combined product innovation and marketing organization to further extend its lead in digital orthodontics and dentistry by enabling greater organizational speed, agility and impact across customer channels and consumers. The new Product, Innovation, and Marketing organization led by Raj Pudipeddi, Align senior vice president and chief marketing, product and business development officer, will combine IT and R&D with Product Management and Global Marketing under one integrated organization responsible for the entire product lifecycle, from customer insights and ideation, to product innovation designing delightful customer and consumer experiences on the Align digital platform, to commercialization and go-to-market strategy. Sreelakshmi Kolli, Align senior vice president, global information technology, will continue to lead IT and also take the lead for end-to-end software engineering as part of this new organization, reporting to Mr. Pudipeddi and continuing to serve on the executive management committee. Zelko Relic, Align senior vice president and chief technology officer, will fully focus on future technologies and digital innovation strategies, as well as cyber security. He will also lead the integration of exocad after the anticipated closing of Align’s acquisition in the second quarter of 2020.

Align Technology Creates Integrated Product, Innovation and Marketing Organization Optimized for Align Digital Platform and Continuous Pace of Innovation

This acquisition is expected to boost Align Technology's (ALGN) portfolio of Invisalign and iTero digital solutions.

Align Technology to Acquire exocad in Digital Dentistry Space

Henry Schein

Medtronic

As the coronavirus chaos continues to rise, MedTech firms have been witnessing a spike in demand for protective respiratory equipment.

3 MedTech Stocks to Rebound After Coronavirus-Led Recoil

The acquisition moves the Invisalign-focused company further into digital dentistry.

Align Technology Acquires a Computer-Aided Dentistry Expert

Align Technology Inc. ALGN, +4.52% said late Wednesday that it plans to buy Exocad from Global Holdings GmbH for €376 million ($418.7 million) in cash.

Align Technology to acquire dental software maker

Investors continue to be optimistic about Align Technology (ALGN) on its strong segmental performance in Q4.

Here's Why You Should Hold on to Align Technology for Now

AmerisourceBergen

ABC vs. ALGN: Which Stock Is the Better Value Option?

ABC or ALGN: Which Is the Better Value Stock Right Now?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Why Is Align Technology (ALGN) Down 14.8% Since Last Earnings Report?

Artisan Partners Asset Management

Balchem

Conagra Brands

JELD-WEN Hld

Roku

Workday

The markets have experienced a significant correction over the past week. These seven stocks to buy are down but not out.

7 Stocks to Buy Down 10% in the Last Week

Align Technology shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
The post Align Technology Shows Improved Relative Strength; Still Shy Of Benchmark appeared first on Investor's Business Daily.

Align Technology Shows Improved Relative Strength; Still Shy Of Benchmark

Clinical treatment plan placed within actual image of a patient’s face to help doctors and patients visualize and compare treatment options Clinical treatment plan placed within actual image of a patient’s face to help doctors and patients visualize and compare treatment options

Align Technology Launches ClinCheck® “In-Face” Visualization Tool for the Invisalign Go System

Align Technology: An Investing-Risk Learning, Profit-Gaining Opportunity

We are upbeat about Align's (ALGN) consistent uptrend in Invisalign volumes across all geographies.

Align (ALGN) Rides on Volume Expansion Despite Cost Concerns

SAN JOSE, Calif., Feb.  03, 2020  (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced its commitment to donate RMB 1 Million to the  Chinese Red Cross Foundation  to support its ongoing prevention and control efforts for the outbreak of the novel coronavirus in China.

Align Technology Pledges RMB 1 Million Donation in Response to the Novel Coronavirus Outbreak in China

The company posted impressive revenue and earnings growth, but the coronavirus scare in China is likely to affect its Q1 results.

Coronavirus Worries Overshadow Align Technology's Solid Q4 Earnings

We are upbeat about Align Technology's (ALGN) continued momentum in Invisalign volumes across all geographies during Q4.

Align Technology (ALGN) Earnings Beat in Q4, Margins Rise

Align Technology, Inc. (ALGN) CEO Joseph Hogan on Q4 2019 Results - Earnings Call Transcript

Align Technology Inc. ALGN, -2.32% shares fell 3.4% in the extended session Wednesday after the company tempered first-quarter expectations because of the coronavirus threat.

Align Technology stock falls after outlook reflects coronavirus concerns

Late Wednesday, Invisalign-maker Align Technology reported adjusted earnings of $1.53 per share on $534 million in sales for its fourth quarter.

Invisalign-Maker Plunges After First-Quarter Guidance Lags Expectations

McKesson

MCK vs. ALGN: Which Stock Is the Better Value Option?

MCK vs. ALGN: Which Stock Should Value Investors Buy Now?

Envista Holdings Corp

These two dental products companies battle for investors’ attention. Which stock is more attractive?

Better Buy: Align Technology Vs. Envista

Align Technology (ALGN) is expected to have gained from continued adoption of Invisalign system in Q4.

News for Align Technology Stock (ALGN)